IBDEI20A ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33587,1,4,0)
 ;;=4^F18.24
 ;;^UTILITY(U,$J,358.3,33587,2)
 ;;=^5003397
 ;;^UTILITY(U,$J,358.3,33588,0)
 ;;=F70.^^148^1668^1
 ;;^UTILITY(U,$J,358.3,33588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33588,1,3,0)
 ;;=3^Intellectual Disabilities,Mild
 ;;^UTILITY(U,$J,358.3,33588,1,4,0)
 ;;=4^F70.
 ;;^UTILITY(U,$J,358.3,33588,2)
 ;;=^5003668
 ;;^UTILITY(U,$J,358.3,33589,0)
 ;;=F71.^^148^1668^2
 ;;^UTILITY(U,$J,358.3,33589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33589,1,3,0)
 ;;=3^Intellectual Disabilities,Moderate
 ;;^UTILITY(U,$J,358.3,33589,1,4,0)
 ;;=4^F71.
 ;;^UTILITY(U,$J,358.3,33589,2)
 ;;=^5003669
 ;;^UTILITY(U,$J,358.3,33590,0)
 ;;=F72.^^148^1668^3
 ;;^UTILITY(U,$J,358.3,33590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33590,1,3,0)
 ;;=3^Intellectual Disabilities,Severe
 ;;^UTILITY(U,$J,358.3,33590,1,4,0)
 ;;=4^F72.
 ;;^UTILITY(U,$J,358.3,33590,2)
 ;;=^5003670
 ;;^UTILITY(U,$J,358.3,33591,0)
 ;;=F73.^^148^1668^4
 ;;^UTILITY(U,$J,358.3,33591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33591,1,3,0)
 ;;=3^Intellectual Disabilities,Profound
 ;;^UTILITY(U,$J,358.3,33591,1,4,0)
 ;;=4^F73.
 ;;^UTILITY(U,$J,358.3,33591,2)
 ;;=^5003671
 ;;^UTILITY(U,$J,358.3,33592,0)
 ;;=F78.^^148^1668^5
 ;;^UTILITY(U,$J,358.3,33592,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33592,1,3,0)
 ;;=3^Intellectual Disabilities,Oth Specified
 ;;^UTILITY(U,$J,358.3,33592,1,4,0)
 ;;=4^F78.
 ;;^UTILITY(U,$J,358.3,33592,2)
 ;;=^5003672
 ;;^UTILITY(U,$J,358.3,33593,0)
 ;;=F79.^^148^1668^6
 ;;^UTILITY(U,$J,358.3,33593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33593,1,3,0)
 ;;=3^Intellectual Disabilities,Unspec
 ;;^UTILITY(U,$J,358.3,33593,1,4,0)
 ;;=4^F79.
 ;;^UTILITY(U,$J,358.3,33593,2)
 ;;=^5003673
 ;;^UTILITY(U,$J,358.3,33594,0)
 ;;=Z00.6^^148^1669^1
 ;;^UTILITY(U,$J,358.3,33594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33594,1,3,0)
 ;;=3^Exam of Participant of Control in Clinical Research Program
 ;;^UTILITY(U,$J,358.3,33594,1,4,0)
 ;;=4^Z00.6
 ;;^UTILITY(U,$J,358.3,33594,2)
 ;;=^5062608
 ;;^UTILITY(U,$J,358.3,33595,0)
 ;;=F45.22^^148^1670^1
 ;;^UTILITY(U,$J,358.3,33595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33595,1,3,0)
 ;;=3^Body Dysmorphic Disorder
 ;;^UTILITY(U,$J,358.3,33595,1,4,0)
 ;;=4^F45.22
 ;;^UTILITY(U,$J,358.3,33595,2)
 ;;=^5003588
 ;;^UTILITY(U,$J,358.3,33596,0)
 ;;=F45.20^^148^1670^2
 ;;^UTILITY(U,$J,358.3,33596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33596,1,3,0)
 ;;=3^Hypochondiacal Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,33596,1,4,0)
 ;;=4^F45.20
 ;;^UTILITY(U,$J,358.3,33596,2)
 ;;=^5003586
 ;;^UTILITY(U,$J,358.3,33597,0)
 ;;=F45.21^^148^1670^4
 ;;^UTILITY(U,$J,358.3,33597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33597,1,3,0)
 ;;=3^Hypochondriasis
 ;;^UTILITY(U,$J,358.3,33597,1,4,0)
 ;;=4^F45.21
 ;;^UTILITY(U,$J,358.3,33597,2)
 ;;=^5003587
 ;;^UTILITY(U,$J,358.3,33598,0)
 ;;=F45.29^^148^1670^3
 ;;^UTILITY(U,$J,358.3,33598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33598,1,3,0)
 ;;=3^Hypochondriacal Disorders NEC
 ;;^UTILITY(U,$J,358.3,33598,1,4,0)
 ;;=4^F45.29
 ;;^UTILITY(U,$J,358.3,33598,2)
 ;;=^5003589
 ;;^UTILITY(U,$J,358.3,33599,0)
 ;;=F45.8^^148^1670^9
 ;;^UTILITY(U,$J,358.3,33599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33599,1,3,0)
 ;;=3^Somatoform Disorders NEC
 ;;^UTILITY(U,$J,358.3,33599,1,4,0)
 ;;=4^F45.8
 ;;^UTILITY(U,$J,358.3,33599,2)
 ;;=^331915
 ;;^UTILITY(U,$J,358.3,33600,0)
 ;;=F45.41^^148^1670^5
 ;;^UTILITY(U,$J,358.3,33600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33600,1,3,0)
 ;;=3^Pain Disorder Exclusively Related to Psychological Factors
